Filing Details

Accession Number:
0001213900-22-079627
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-14 09:00:23
Reporting Period:
2022-12-12
Accepted Time:
2022-12-14 09:00:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
12239 Aikido Pharma Inc. AIKI Pharmaceutical Preparations (2834) 520849320
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1538372 Anthony Hayes One Rockefeller Plaza,
11Th Floor
New York NY 10020
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-12 5,000 $3.63 167,181 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. On December 12, 2022, the reporting person purchased 5,000 shares of common stock in the public market at $3.625 per share.